Andrea Pettenazzo
Overview
Explore the profile of Andrea Pettenazzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
462
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonardi C, Nosadini M, Lorenzoni G, Tessari A, Santoro L, Pettenazzo A, et al.
Clin Pediatr (Phila)
. 2023 Dec;
63(10):1379-1386.
PMID: 38142368
Appropriate status epilepticus (SE) management is key to minimize admission to the pediatric intensive care unit (PICU). We retrospectively describe 115 children admitted to the PICU of the tertiary-care referral...
2.
Bonardi C, Furlanis G, Toldo I, Guarrera B, Luisi C, Pettenazzo A, et al.
Brain Dev
. 2023 Feb;
45(5):293-299.
PMID: 36725381
Background: Febrile infection-related epilepsy syndrome (FIRES) is a rare and catastrophic clinical syndrome occurring in previously healthy patients. Aetiology is still unknown and outcome usually poor. We describe a case...
3.
Tessari A, Sperotto F, Pece F, Pettenuzzo G, Porcellato N, Poletto E, et al.
Pharmacotherapy
. 2022 Dec;
43(7):622-631.
PMID: 36567489
Study Objective: We aimed to evaluate the efficacy and safety of ketamine in ensuring comfort and sparing conventional drugs when used as an adjuvant for analgesia and sedation in the...
4.
Poletto E, Cavagnero F, Pettenazzo M, Visentin D, Zanatta L, Zoppelletto F, et al.
Front Pediatr
. 2022 Oct;
10:1044681.
PMID: 36313866
[This corrects the article DOI: 10.3389/fped.2022.867739.].
5.
Carnevale F, Giannini A, Bonaldi A, Bravi E, Cecchi C, Pettenazzo A, et al.
Ital J Pediatr
. 2021 Jul;
47(1):153.
PMID: 34233717
Objectives: To investigate how life-sustaining treatment (LST) decisions are made and identify problematic ethical concerns confronted by physicians and nurses in pediatric intensive care within Italy. Methods: An 88-question online...
6.
Meneghel A, Martini G, Amigoni A, Pettenazzo A, Padalino M, Zulian F
Front Pediatr
. 2021 Feb;
8:635080.
PMID: 33537271
Macrophage activation syndrome (MAS) is a rare, potentially life-threatening, condition triggered by infections or flares in rheumatologic and neoplastic diseases. The mainstay of treatment includes high dose corticosteroids, intravenous immunoglobulins...
7.
Biban P, Conti G, Wolfler A, Carlassara S, Gitto E, Rulli I, et al.
BMJ Open
. 2020 Oct;
10(10):e038780.
PMID: 33077567
Introduction: Some evidence indicates that exogenous surfactant therapy may be effective in infants with acute viral bronchiolitis, even though more confirmatory data are needed. To date, no large multicentre trials...
8.
Mercolini F, Di Leo V, Bordin G, Melotti R, Sperotto F, Pettenazzo A, et al.
Pediatr Crit Care Med
. 2020 Oct;
22(1):e1-e9.
PMID: 33009360
Objectives: To evaluate the ability to predict central venous pressure by ultrasound measured inferior vena cava and aortic diameters in a PICU population and to assess interoperator concordance. Design: Noninterventional...
9.
Sperotto F, Cogo P, Amigoni A, Pettenazzo A, Thiagarajan R, Polito A
Crit Care Explor
. 2020 Sep;
2(9):e0183.
PMID: 32984825
Objectives: Extracorporeal membrane oxygenation has been used to support children who fail to wean from cardiopulmonary bypass after pediatric cardiac surgery, but little is known about outcomes. We aimed to...
10.
Mondardini M, Sperotto F, Daverio M, Caramelli F, Gregori D, Caligiuri M, et al.
Trials
. 2019 Dec;
20(1):710.
PMID: 31829274
Background: Prolonged treatment with analgesic and sedative drugs in the pediatric intensive care unit (PICU) may lead to undesirable effects such as dependence and tolerance. Moreover, during analgosedation weaning, patients...